Vioxx-Like Drug Gets Mixed Reviews
13th Nov 2006, 20:17 GMT
CHICAGO — The first published studies of Arcoxia, the drug that Merck & Co. hopes will take the place of its withdrawn painkiller Vioxx, are getting mixed reviews from doctors, some of whom say the results do not make a case for the medication's approval.
Vioxx-Like Drug Gets Mixed Reviews related news:
- Mixed reviews for Vioxx successor — MSNBC.com: Health
- Merck's Arcoxia Draws Mixed Reviews — WSJ.com: US Business
- Vioxx-Like Drug Gets Mixed Reviews — StratWire - Business of Healthcare NewsFeed
- Results on Merck's new painkiller draw mixed reviews — azcentral.com | business
- Docs Give Merck Painkiller Acroxia Mixed Reviews — FOXNews.com
- Results Mixed on Merck's New Painkiller — LancasterOnline - Health
- Results mixed on Merck's new painkiller (AP) — Yahoo! News: Health News
- Results mixed on Merck's new painkiller (Associated Press) — Yahoo! Health: Health News
- Tests of new Merck painkiller criticized — baltimoresun.com - health & science
- Merck says new drug is safer than Vioxx — Cardiology News from StratCenter.com
Latest news from Dayton Daily News National Headlines:
- Edmund Fitzgerald's Sinking Commemorated
- Friends Say Accused Marine Is Loyal
- California Wildfire Burns 125 Acres
- Americans Adventuresome in Study Abroad
- 21-Vehicle Crash Closes Conn. Highway
- Poll: Most Doubt Dems Have Plan for Iraq
- Citizenship Test to Focus on Democracy
- Six Held Hostage at Pharmacy
- Ill. Woman Accused in Hit-And-Run Death
- Police in Standoff With Florida Man